Jia Shi
...d incidence of treatment responders in comparison to non-responders was significantly lower (OR = 0.78, CI (0.7-0.87), p <0.0001). High heterogeneity was observed in this analysis (I2 = 95%, p <0.0001). to investigate factors affecting heterogeneity, a subgroup analysis was done based on the HBV genotype. 5 Studies in which most patients ...
Noora Hassan Hezam Al-Aqmer1*, Zain Aamir2, Muhammad Farooq Hanif3, Soumble Zulfiqar4, Sibgha Zulfiqar1, Mateen Izhar5 and Abdul Rauf Shakoori4*
...otypes AA, Aa, and aa in responders and 22 (33.3%), 26 (39.4%), and 18 (27.3%) in non-responders. The allelic distribution was 83 (62.9%) and 49 (37.1%) for the “A” and “a” alleles in responders and 70 (53%) and 62 (47%) in non-responders. ApaI genotype ‘’aa’’ was found to be a significant predictor of trea...
Hemeida, A. A., Osman, M., El-Shahat, Mohamed, Hashem, Medhat H., Mahmoud, Amal and Dahi, Hosni
... 25 patients (27.2%) non responders (group B). The two groups were Screened for Serum alanine transaminase (ALT), Serum aspartate transaminase (AST), Serum alpha fetoprotein (AFP) , serum Albumin , serum creatinine , Serum TSH, Hemoglobin (Hb),White blood cells count (WBCs) and Platelets count . Hematological disorders and ALT elevation were common side effects of treatment. The side effects were increased within group B than that of group A. Three random hepa...
Muhammad Shahid1, Iram Amin1*, Rabia Nawaz1,3, Samia Afzal1, Afza Rasul2, Muhammad Umer Khan4, Fatima Arshad Butt1 and Muhammad Idrees1
..., and monocyte % between responders and non-responders have been statistically significant (P < 0.05). In the predictive analysis, three variables γ-GT, globulin, and albumin were predictors of treatment. Our study showed that clinical and virological parameters can be used as a useful tool for predicting treatment outcomes. These parameters can be used to accurate predictions of the Pakistani population in patients...
